ConductScience.org, home
Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus
API referenceFor AI assistants

Trial · NCT00410202

Participant flow24

How many started, completed or left each group, period by period.

1 to 20 of 24

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
On-TreatmentSTARTEDEntecavir + Adefovir (ETV+ADV) Combination Therapy138
On-TreatmentSTARTEDEntecavir (ETV) Monotherapy140
On-TreatmentSTARTEDAdefovir + Lamivudine (ADV+LVD) Combination Therapy137
On-TreatmentDiscontinued Prior to Week 48 VisitEntecavir + Adefovir (ETV+ADV) Combination Therapy4
On-TreatmentDiscontinued Prior to Week 48 VisitEntecavir (ETV) Monotherapy2
On-TreatmentDiscontinued Prior to Week 48 VisitAdefovir + Lamivudine (ADV+LVD) Combination Therapy2
On-TreatmentDiscontinued at or After Week 48 VisitEntecavir + Adefovir (ETV+ADV) Combination Therapy2
On-TreatmentDiscontinued at or After Week 48 VisitEntecavir (ETV) Monotherapy6
On-TreatmentDiscontinued at or After Week 48 VisitAdefovir + Lamivudine (ADV+LVD) Combination Therapy3
On-TreatmentCOMPLETEDEntecavir + Adefovir (ETV+ADV) Combination Therapy63
On-TreatmentCOMPLETEDEntecavir (ETV) Monotherapy61
On-TreatmentCOMPLETEDAdefovir + Lamivudine (ADV+LVD) Combination Therapy66
On-TreatmentNOT COMPLETEDEntecavir + Adefovir (ETV+ADV) Combination Therapy75
On-TreatmentNOT COMPLETEDEntecavir (ETV) Monotherapy79
On-TreatmentNOT COMPLETEDAdefovir + Lamivudine (ADV+LVD) Combination Therapy71
Off-treatment Follow upSTARTEDEntecavir + Adefovir (ETV+ADV) Combination Therapy15
Off-treatment Follow upSTARTEDEntecavir (ETV) Monotherapy8
Off-treatment Follow upSTARTEDAdefovir + Lamivudine (ADV+LVD) Combination Therapy14
Off-treatment Follow upCOMPLETEDEntecavir + Adefovir (ETV+ADV) Combination Therapy1
Off-treatment Follow upCOMPLETEDEntecavir (ETV) Monotherapy0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00410202/flow

API referenceFor AI assistants